Literature DB >> 8855552

Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum.

J R Vásquez1, L Goozé, K Kim, J Gut, C Petersen, R G Nelson.   

Abstract

We have determined the nucleic acid sequences of a gene encoding the bifunctional enzyme dihydrofolate reductase-thymidylate synthase (DHFR-TS) from bovine and human AIDS isolates of Cryptosporidium parvum. THe DHFR-TS gene was isolated from genomic DNA libraries by hybridization with a probe amplified from C. parvum genomic DNA using generic TS primers in the polymerase chain reaction. Genomic Southern and electrophoretic karyotype analyses reveal C. parvum DHFR-TS is a single-copy gene on a 1200-kb chromosome. The DHFR-TS nucleic acid sequence contains no introns and the single 1563-bp open reading frame encodes a 179 residue N-terminal DHFR domain connected by a 55 amino acid junction peptide to a 287 residue C-terminal TS domain. The sequences of the DHFR-TS gene from the bovine and human C. parvum isolates differ at two positions in the 5'-flanking sequence and at 38 positions in the encoding sequence. These DNA sequence polymorphisms will provide a powerful probe to examine the genotypic diversity and genetic population structure of C. parvum. The two sequences encode identical TS domains which share all except one of the phylogenetically conserved amino acid residues identified among reported TS sequences. The predicted DHFR domain sequences contain nine amino acid differences; these polymorphisms all map to non-active site, surface locations in known DHFR structures. The C. parvum DHFR active site contains novel residues at several positions analogous to those at which point mutations have been shown to produce antifolate resistance in other DHFRs. Thus C. parvum DHFR may be intrinsically resistant ti inhibition by some antifolate DHFR inhibitors which may explain why cryptosporidiosis is refractory to treatment with the clinically common antibacterial and antiprotozoal antifolates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855552     DOI: 10.1016/0166-6851(96)02647-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  32 in total

1.  The Cryptosporidium "mouse" genotype is conserved across geographic areas.

Authors:  U M Morgan; A P Sturdee; G Singleton; M S Gomez; M Gracenea; J Torres; S G Hamilton; D P Woodside; R C Thompson
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Site-directed ligand discovery.

Authors:  D A Erlanson; A C Braisted; D R Raphael; M Randal; R M Stroud; E M Gordon; J A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages.

Authors:  M E Perkins; Y A Riojas; T W Wu; S M Le Blancq
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

4.  Molecular characterization of Cryptosporidium spp. from children in Kolkata, India.

Authors:  Pradeep Das; Seuli Saha Roy; Kakali MitraDhar; Phalguni Dutta; Mihir K Bhattacharya; Abhik Sen; Sandipan Ganguly; Sujit K Bhattacharya; Altaf A Lal; Lihua Xiao
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

5.  Explaining an unusually fast parasitic enzyme: folate tail-binding residues dictate substrate positioning and catalysis in Cryptosporidium hominis thymidylate synthase.

Authors:  W Edward Martucci; Melissa A Vargo; Karen S Anderson
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

Review 6.  Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Authors:  Mahmoud H El Kouni
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-07-21       Impact factor: 2.231

7.  Multilocus genetic analysis of Cryptosporidium parvum from Egypt.

Authors:  Said Amer; Masoud Fayed; Hajime Honma; Yasuhiro Fukuda; Chica Tada; Yutaka Nakai
Journal:  Parasitol Res       Date:  2010-07-13       Impact factor: 2.289

8.  Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.

Authors:  Vidya P Kumar; Jose A Cisneros; Kathleen M Frey; Alejandro Castellanos-Gonzalez; Yiqiang Wang; Aleem Gangjee; A Clinton White; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2014-07-24       Impact factor: 2.823

9.  Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.

Authors:  W Edward Martucci; Marina Udier-Blagovic; Chloe Atreya; Oladapo Babatunde; Melissa A Vargo; William L Jorgensen; Karen S Anderson
Journal:  Bioorg Med Chem Lett       Date:  2008-11-20       Impact factor: 2.823

10.  Gene transfer in the evolution of parasite nucleotide biosynthesis.

Authors:  Boris Striepen; Andrea J P Pruijssers; Jinling Huang; Catherine Li; Marc-Jan Gubbels; Nwakaso N Umejiego; Lizbeth Hedstrom; Jessica C Kissinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.